Tech Company Financing Transactions
Pathway Therapeutics Funding Round
Pathway Therapeutics closed a $200 thousand investment round on 11/30/2012. Investors included private investors.
Transaction Overview
Company Name
Announced On
11/30/2012
Transaction Type
Debt
Amount
$200,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
409 Illinois Street
San Francisco, CA 94158
USA
San Francisco, CA 94158
USA
Phone
Website
Email Address
Overview
Pathway Therapeutics is a clinical stage, privately held, pharmaceutical company developing differentiated and best in class isoform specific PI3-kinase (PI3K) inhibitors for oncology, inflammatory and respiratory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Julie Cherrington
VP - Bus. Development
Sanjay Lakhotia
Browse more venture capital transactions:
Prev: 11/29/2012: CapLinked venture capital transaction
Next: 11/30/2012: Rent the Runway venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to record every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs